About Arc Trinova
Arc Trinova is a company based in Alnwick (United Kingdom) founded in 2016 was acquired by Quotient Sciences in February 2021. Arc Trinova has raised $6.64 million across 3 funding rounds from investors including Quotient Sciences, UK Research and Innovation and BGF. Arc Trinova operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Alnwick, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.64 M (USD)
in 3 rounds
-
Latest Funding Round
$1.28 M (USD), Grant
Dec 07, 2018
-
Investors
Quotient Sciences
& 2 more
-
Employee Count
Not available
-
Acquired by
Quotient Sciences
(Feb 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Arc Trinova
Arc Trinova has successfully raised a total of $6.64M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.28 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Arc Trinova
Arc Trinova has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Quotient Sciences, UK Research and Innovation and BGF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Locked | Locked | Locked | |
|
Research and innovation funding is managed for UK advancement.
|
Locked | Locked | Locked | |
|
APIs and finished dosage forms are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for Arc Trinova
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arc Trinova
Investment portfolio details for Arc Trinova
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Arc Trinova
Detailed financials for Arc Trinova
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arc Trinova Comparisons
Peer comparison for Arc Trinova
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arc Trinova
Arc Trinova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
Detailed competitors of Arc Trinova
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arc Trinova
Complete news archive for Arc Trinova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arc Trinova
Arc Trinova was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Arc Trinova is headquartered in Alnwick, United Kingdom.
Arc Trinova is a funded company, having raised a total of $6.64M across 3 funding rounds to date.
Arc Trinova was established in 2016 and is headquartered in Alnwick, United Kingdom. Operations focus on the life sciences sector, where contract manufacturing for pharmaceutical products is handled alongside bioanalytical testing and regulatory consulting. Services support drug development processes, including formulation, stability analysis, and compliance advisory. The company serves clients across Europe through its integrated facilities and expertise in outsourced solutions.
Arc Trinova's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Arc Trinova has 3 investors. Key investors include Quotient Sciences, UK Research and Innovation, and BGF.